Palomino Laboratories (PALX) Operating Expenses (2023 - 2025)

Palomino Laboratories has disclosed Operating Expenses across 3 years of filings, most recently posting -$1.9 million for Q4 2025.

• Operating Expenses for Q4 2025 came in at -$1.9 million, down 1499.08% year-over-year; the trailing twelve-month figure through Dec 2025 was -$271897.0 (down 222.32% YoY), and the FY2025 annual result was $30000.0, down 78.58% from the prior year.
• Operating Expenses came in at -$1.9 million for Q4 2025 at Palomino Laboratories, down from $1.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.6 million in Q3 2025 to a low of -$1.9 million in Q4 2025.
• The 3-year median for Operating Expenses is $32182.5 (2023), against an average of $2860.9.
• Peak annual rise in Operating Expenses reached 129958.51% in 2025, while the deepest fall reached 1499.08% in 2025.
• Palomino Laboratories' Operating Expenses stood at $32574.0 in 2023, then jumped by 323.53% to $137962.0 in 2024, then slumped by 1499.08% to -$1.9 million in 2025.
• The last three Operating Expenses figures came in at -$1.9 million (Q4 2025), $1.6 million (Q3 2025), and $35548.0 (Q2 2025), per Business Quant data.